Ignite Creation Date:
2024-05-06 @ 2:21 PM
Last Modification Date:
2024-10-26 @ 1:29 PM
Study NCT ID:
NCT04293289
Status:
COMPLETED
Last Update Posted:
2023-02-08
First Post:
2020-02-25
Brief Title:
Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma
Sponsor:
Cancer Intelligence Care Systems Inc
Organization:
Cancer Intelligence Care Systems Inc
Study Overview
Official Title:
Phase 1 Clinical Trial of Boron Neutron Capture Therapy BNCT Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma
Status:
COMPLETED
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Among skin malignancies patients with malignant melanoma or angiosarcoma are treated with BNCT using CICS-1 and SPM-011 borofalan 10B Through this trial safety and appropriate treatment dose will be determined
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None